Dr. Reddy's Laboratories RDY announced yesterday that it has
launched Donepezil Hydrochloride Tablets, 23 mg, a therapeutic
equivalent generic version of ARICEPT®, 23 mg in the U.S.
market on July 26, 2013, following the approval by the United States
Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Donepezil
Hydrochloride Tablets, 23 mg.
The ARICEPT®, 23 mg brand had U.S. sales of approximately
$92.6 Million MAT for the most recent twelve months ending in May 2013
according to IMS Health*.
Dr. Reddy's Donepezil Hydrochloride Tablets, 23 mg is available in
bottle count sizes of 30 and 90.
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in